tiprankstipranks
Milestone Pharmaceuticals (MIST)
NASDAQ:MIST
US Market
MIST
Milestone Pharmaceuticals
RESEARCH TOOLSreports
Want to see MIST full AI Analyst Report?

Milestone Pharmaceuticals (MIST) Stock News & Sentiment

797 Followers
Milestone Pharmaceuticals’ Earnings Call Signals Early Momentum
Premium
Company Announcements
Milestone Pharmaceuticals’ Earnings Call Signals Early Momentum
10d ago
MIST
Milestone Pharmaceuticals’ Earnings Call Highlights Early Launch Momentum
Premium
Company Announcements
Milestone Pharmaceuticals’ Earnings Call Highlights Early Launch Momentum
16d ago
MIST
Buy Rating Reiterated on Milestone as Cardamyst Traction Grows and AFib Program Advances; $8 Price Target Unchanged
Premium
Ratings
Buy Rating Reiterated on Milestone as Cardamyst Traction Grows and AFib Program Advances; $8 Price Target Unchanged
16d ago
MIST
Analyst Reiterates Buy on MIST, Maintains $8 Price Target on Strong CARDAMYST Launch and Expanded AFib Opportunity
Premium
Ratings
Analyst Reiterates Buy on MIST, Maintains $8 Price Target on Strong CARDAMYST Launch and Expanded AFib Opportunity
16d ago
MIST
Milestone Pharmaceuticals (MIST) Q1 Earnings Cheat Sheet
Premium
Pre-Earnings
Milestone Pharmaceuticals (MIST) Q1 Earnings Cheat Sheet
19d ago
MIST
Regulatory Disruptions Pose Material Operational Risks for Milestone Pharmaceuticals
Premium
Company Announcements
Regulatory Disruptions Pose Material Operational Risks for Milestone Pharmaceuticals
2M ago
MIST
Milestone: Early CARDAMYST Launch Progress and Solid Cash Position Underscore Buy Rating and $8 Target
Premium
Ratings
Milestone: Early CARDAMYST Launch Progress and Solid Cash Position Underscore Buy Rating and $8 Target
2M ago
MIST
More MIST News >

MIST News on the Web

Analysts Offer Insights on Healthcare Companies: Alpha Tau Medical Ltd (DRTS), Neurogene (NGNE) and Milestone Pharmaceuticals (MIST)
TipRanks News
Bullish
Milestone Pharmaceuticals’ Earnings Call Signals Early Momentum
TipRanks News
Bullish
Milestone Pharmaceuticals (MIST) Gets a Buy from Piper Sandler
TipRanks News
Bullish
Milestone Pharmaceuticals’ Earnings Call Highlights Early Launch Momentum
TipRanks News
Neutral
Why Milestone Pharmaceuticals Stock Wilted on Wednesday | The Motley Fool
Motley Fool
Neutral
Milestone Pharmaceuticals files $300M mixed securities shelf
TipRanks News
Neutral
Buy Rating Reiterated on Milestone as Cardamyst Traction Grows and AFib Program Advances; $8 Price Target Unchanged
TipRanks News
Bullish
Milestone Pharmaceuticals Q1 Earnings Call Highlights
MarketBeat
Bullish

News Score - Last 7 Days

Very Positive
MIST
Sector Average
Media Buzz
This Week1 articles
Weekly Average2.75 articles
News Sentiment
This Week99%
Sector Average79%
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is MIST’s Media Buzz Sentiment?
1 articles about MIST were published this week. In an average week, 2.75 articles are published.
    What is MIST’s weekly average amount of articles?
    In an average week, 2.75 articles about MIST are published.
      What is MIST’s News Sentiment?
      99% of articles about MIST were positive this week, compared to its sector average of 79%.
        Healthcare Stocks that are Trending in the News
        AKTXAkari Therapeutics
        IMMXImmix Biopharma
        SYSo-Young International
        ADOAnteoTech Ltd
        FSPKFFisher & Paykel Healthcare Corporation Limited
        Showing the stocks with the most bullish news sentiment over the past week